We are live on ! Find out more
PAM

Panagora Asset Management Portfolio holdings

AUM $26.7B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+36.4%
3 Year Est. Return
+128.64%
5 Year Est. Return
+186.75%
10 Year Est. Return
+733.24%
AUM
$26.6B
AUM Growth
+$1.35B
Cap. Flow
-$197M
Cap. Flow %
-0.74%
Top 10 Hldgs %
19.6%
Holding
2,577
New
197
Increased
755
Reduced
974
Closed
156

Sector Composition

Rank Sector Weight
1 Technology 17.98%
2 Financials 16.77%
3 Healthcare 13.5%
4 Consumer Discretionary 11.08%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTOL icon
776
Bristow Group
VTOL
$1.31B
$2.37M 0.01%
96,125
-9,726
-9% -$248K
AMAT icon
777
Applied Materials
AMAT
$424B
$2.37M 0.01%
61,228
-453,971
-88% -$20.1M
HE icon
778
Hawaiian Electric Industries
HE
$2.17B
$2.37M 0.01%
66,439
-87,716
-57% -$3.09M
DISCK
779
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2.37M 0.01%
79,965
+45,632
+133% +$1.19M
PYPL icon
780
PayPal
PYPL
$49.6B
$2.35M 0.01%
26,702
-566
-2% -$49.8K
CLX icon
781
Clorox
CLX
$12.8B
$2.34M 0.01%
15,586
-2,364
-13% -$336K
TPCO
782
DELISTED
Tribune Publishing Company Common Stock
TPCO
$2.34M 0.01%
143,525
+1,947
+1% +$32.3K
IBTX
783
DELISTED
Independent Bank Group, Inc.
IBTX
$2.34M 0.01%
+35,360
New +$2.41M
ASRT
784
DELISTED
Assertio
ASRT
$2.33M 0.01%
6,618
+5,052
+323% +$2.21M
ENV
785
DELISTED
ENVESTNET, INC.
ENV
$2.33M 0.01%
38,309
-14,643
-28% -$885K
DXPE icon
786
DXP Enterprises
DXPE
$2.61B
$2.32M 0.01%
57,866
-17,585
-23% -$766K
CPRX
787
DELISTED
Catalyst Pharmaceutical
CPRX
$2.31M 0.01%
611,450
+333,821
+120% +$1.05M
LAUR icon
788
Laureate Education
LAUR
$5.24B
$2.29M 0.01%
+148,521
New +$2.29M
JBLU icon
789
JetBlue
JBLU
$2.4B
$2.27M 0.01%
117,531
+109,204
+1,311% +$2.07M
CNCE
790
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.27M 0.01%
152,818
-81,288
-35% -$1.28M
TWLO icon
791
Twilio
TWLO
$29.3B
$2.25M 0.01%
+26,089
New +$1.91M
UPLD icon
792
Upland Software
UPLD
$12.8M
$2.25M 0.01%
6,951
ROL icon
793
Rollins
ROL
$18.1B
$2.24M 0.01%
83,063
-5,745
-6% -$148K
GS icon
794
Goldman Sachs
GS
$313B
$2.24M 0.01%
9,976
-219
-2% -$50.9K
RMBS icon
795
Rambus
RMBS
$10.6B
$2.23M 0.01%
204,489
+81,631
+66% +$993K
EXTN
796
DELISTED
Exterran Corporation
EXTN
$2.23M 0.01%
84,077
-29,420
-26% -$790K
FAST icon
797
Fastenal
FAST
$57.4B
$2.23M 0.01%
153,572
+75,160
+96% +$1.07M
MZTI
798
The Marzetti Company
MZTI
$3.05B
$2.23M 0.01%
14,917
VRTU
799
DELISTED
Virtusa Corporation
VRTU
$2.22M 0.01%
41,274
-1,468
-3% -$79.8K
LGTY
800
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$2.21M 0.01%
181,997
+18,532
+11% +$280K

Similar funds

Panagora Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Panagora Asset Management held 2,577 positions worth $26.6B, up 5.4% from $25.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Panagora Asset Management's Q3 2018 filing shows 197 new, 755 increased, 974 reduced and 156 closed positions. Its largest new stake was iShares MSCI Taiwan ETF: 213,682 shares worth $8.06M. The largest sale was PNC Financial Services, an estimated $135M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Panagora Asset Management's largest Q3 2018 buy was iShares MSCI Taiwan ETF: 213,682 shares worth $8.06M.
  • Panagora Asset Management added most to Bristol-Myers Squibb in Q3 2018, an estimated $135M increase.
  • Panagora Asset Management's biggest Q3 2018 reduction was PNC Financial Services, cutting an estimated $135M.
  • Panagora Asset Management fully exited Canadian Imperial Bank of Commerce in Q3 2018, selling an estimated $23.9M.
  • Panagora Asset Management's ten largest holdings make up 20% of its $26.6B portfolio in Q3 2018.
  • Panagora Asset Management opened 197 new positions and closed 156 in Q3 2018.
  • Panagora Asset Management's portfolio value rose 5.4% quarter-over-quarter to $26.6B.

Based on Panagora Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.